reports
DSV - Q1 2025 results and expected completion of Schenker acquisition ...
DSV - Q1 2025 results and expected completion of Schenker acquisition analyst conference call We expect to complete the announced acquisition of Schenker and release the Q1 2025 interim results of DSV A/S on 30 April 2025. A conference call is scheduled for 11:30 am CEST. At the conference call, Jens H. Lund, Group CEO, and Michael Ebbe, Group CFO, will present the Q1 2025 Interim Financial Report as well as further details and preliminary financial information related to the acquisition of Schenker. The presentation will be followed by a Q&A session. Date: 30 April 202...
DSV, 1153 - DSV OBTAINS ALL REGULATORY CLEARANCES FOR THE ACQUISITION ...
DSV, 1153 - DSV OBTAINS ALL REGULATORY CLEARANCES FOR THE ACQUISITION OF SCHENKER Company Announcement No. 1153 As of today, all closing conditions for DSV A/S’ pending acquisition of the global freight forwarding and contract logistics business DB Schenker operated by Schenker AG and its affiliates (“Schenker”) from Deutsche Bahn AG have been fulfilled, including approval by the European Commission and the expiration of the applicable waiting period in the US. Please refer to announcement no. 1132 of 13 September 2024. The parties are now able to complete the transaction, which is expect...
Kuehne + Nagel International AG: 1 director
A director at Kuehne + Nagel International AG bought 15,691 shares at 171.605CHF and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the la...
DSV, 1152 - ANNUAL GENERAL MEETING OF DSV A/S 20 MARCH 2025
DSV, 1152 - ANNUAL GENERAL MEETING OF DSV A/S 20 MARCH 2025 Company Announcement No. 1152The Annual General Meeting of DSV A/S was held today. Agenda and resolutions 1. Report of the Board of Directors and the Executive Board on the Company's activities in 2024The report was not subject for voting. The Annual General Meeting took note of the report. 2. Presentation of the 2024 Annual Report with the audit report for adoptionThe 2024 Annual Report was approved. 3. Resolution on application of profits or covering of losses as per the adopted 2024 Annual ReportThe Board of Directors’ propo...
DSV, 1051 - NOTICE OF ANNUAL GENERAL MEETING 2025
DSV, 1051 - NOTICE OF ANNUAL GENERAL MEETING 2025 Notice of Annual General Meeting Notice is hereby given that the Annual General Meeting of DSV A/S will be held on: Thursday, 20 March 2025, at 14:00 CET, at DSV A/S’ registered office DSV A/SHovedgaden 630, 2640 Hedehusene, Denmark Doors open at 13:00 CET Light refreshments will be served before the Annual General Meeting (from 13:00 CET). 1 Agenda 1. Report of the Board of Directors and the Executive Board on the Company's activities in 2024 2. Presentation of the 2024 Annual Report with the audit report for adoption ...
- Jacob Berg Nielsen
DSV (Buy, TP: DKK1800.00) - Waiting for the Schenker closing
Although Q4 EBIT missed consensus by c8% and the initial 2025 EBIT guidance was cautious, management’s comments provided reassurance about the DSV stand-alone earnings baseline near-term. We believe focus now shifts to the Schenker integration, where we see ample room to realise cost synergies and scope for group EBIT to more than double by 2028e. We reiterate our BUY, but have cut our target price to DKK1,800 (1,850).
- ABGSC Shipping & Transport Research
- Peter Sehested
- ABGSC Shipping & Transport Research
- Peter Sehested
DSV, 1150 - 2024 ANNUAL REPORT
DSV, 1150 - 2024 ANNUAL REPORT Company Announcement No. 1150 Solid financial results in Q4 and full-year 2024 driven by strong organic volume growth The DSV Group improved its performance in Q4 2024 and reported solid full-year results for 2024 driven by continued organic above-market growth.While gross profit decreased by 1.2% compared to 2023 and EBIT before special items by 8.4% in constant currencies, earnings growth returned in the second half of 2024, despite the Road division being impacted by a weaker market in Q4 2024.Adjusted free cash flow came to DKK 5,550 million for the year...
DSV, 1149 - NOMINATION OF NEW BOARD MEMBERS
DSV, 1149 - NOMINATION OF NEW BOARD MEMBERS Company Announcement No. 1149 With reference to Company Announcement No. 1145 on 13 December 2024 and in view of closing of DSV A/S’ anticipated transformational acquisition of Schenker AG, the Board of Directors has decided to nominate Sabine Bendiek and Natalie Shaverdian Riise-Knudsen as members of the Board of Directors for the shareholders’ decision at the next ordinary general meeting of DSV A/S in March 2025. Sabine Bendiek is a German national with extensive executive experience from international IT executive and non-executive leadershi...
- ABGSC Shipping & Transport Research
- Peter Sehested
DSV, 1148 - MAJOR SHAREHOLDER ANNOUNCEMENT
DSV, 1148 - MAJOR SHAREHOLDER ANNOUNCEMENT Company Announcement No. 1148 Pursuant to section 30 of the Danish Capital Markets Act it is hereby announced that BlackRock, Inc. (BlackRock) has informed DSV A/S (DSV) that BlackRock has changed its holding of shares/voting rights and of other financial instruments acc. to section 39(2) of the Danish Capital Markets Act in DSV as follows: Change as of 10 January 2025 BlackRock’s share capital and voting rights in DSVHolding in DSV previouslyHolding in DSV as of 10 January 2025Share capital and voting rights attached to shares in %4.96%5.00%S...
DSV - 2024 Annual Report conference call
DSV - 2024 Annual Report conference call We expect to release the 2024 Annual Report of DSV A/S in the morning of 4 February 2025. A webcast and conference call will be held at 11:00 am CET. At the call, Group CEO Jens H. Lund and Group CFO Michael Ebbe will present the 2024 Annual Report. The presentation will be followed by a Q&A session. Date: 4 February 2025Time: 11:00 am CET To attend the webcast presentation, please go to or . If you would like to ask questions during the conference call, please register through this link: . You will receive an ema...
FedEx Corp: 1 director
A director at FedEx Corp bought 1,000 shares at 273.980USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
- Jonathan Moreland
- ABGSC Shipping & Transport Research
- Peter Sehested
- Jacob Berg Nielsen
- Jonathan Moreland
OXY OCCIDENTAL PETROLEUM CORPORATION
HPP HUDSON PACIFIC PROPERTIES INC.
VVI VIAD CORP
VRSN VERISIGN INC.
OMEX ODYSSEY MARINE EXPLORATION INC.
MMS MAXIMUS INC.
KVHI KVH INDUSTRIES INC.
FPI FARMLAND PARTNERS REIT
FDX FEDEX CORPORATION
DEA EASTERLY GOVERNMENT PROPERTIES INC
CDXS CODEXIS
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
PLSE PULSE BIOSCIENCES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
LW LAMB WESTON HOLDINGS INC.
ANAB ANAPTYSBIO INC.
DMLP DORCHESTER MINERALS L.P.
ZIVO ZIVO BIOSCIENCE
WHLM INC.
LOVE WILHELMINA INTERNATIONAL
FUND LOVESAC
MCFT ROYCE FOCUS TRUST
PGNY INC.
OXLC MASTERCRAFT BOAT HOLDINGS
ZYME PROGYNY
DCTH OXFORD LANE CAPITAL CORP.
REYN ZYMEWORKS INC.
PRLD DELCATH SYSTEMS
DLHC REYNOLDS CONSUMER PRODUCTS INC.
MASS PRELUDE THERAPEUTICS
NOTV DALEIGH HOLDINGS CORP
PFX 908 DEVICES
XLO INOTIV
NVCT INC.
ANEB PHENIXFIN CORP
BHVN XILIO THERAPEUTICS INC
BUKS NUVECTIS PHARMA INC
ECBK ANEBULO PHARMACEUTICALS INC
GLSI BIOHAVEN LTD
MEGI BUTLER NATIONAL CORP
SCWO ECB BANCORP INC.
SRFM GREENWICH LIFESCIENCES INC
OCX MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
SUNS 374WATER INC
SIRI SURF AIR MOBILITY INC.
TXO ONCOCYTE CORPORATION
MRKR SUNRISE REALTY TRUST
TTGT SIRIUS XM HLDGS INC NEW
KALA MORNINGSTAR PARTNERS
DTIL L.P.
MARKER THERAPEUTICS INC
TECHTARGET INC.
KALA BIO INC
PRECISION BIOSCIENCES INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.